Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More
Genomic Data Interpretation
Interpreta, higi, Partners to Integrate Biometric Data for Patient Engagement
Interpreta and higi are announcing a partnership to integrate biometric data from higi with clinical, claims and genomic data from Interpreta. The integration will enable patients and their physicians to increase engagement and share healthcare data (on blood pressure, pulse, BMI, weight, body composition, and self-screening questions) gained at higi retail stations and prioritized within Interpreta in real time.This will enable physicians and insurers to leverage a patient’s biometrics data,
Read More
Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market
Genoox, the genomic analysis company making it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing data has raised $6 million in funding led by Inimiti Capital Partners and Glilot Capital Partners. With this investment, Genoox will also be expanding their genomic services into the U.S. healthcare market, providing medical facilities with innovative solutions to help solve real and pressing healthcare problems. Genoox has an international footprint, with a
Read More
IBM Watson, Illumina Partner to Simplify Genomic Data Interpretation
IBM Watson Health and Illumina are teaming up to standardize and simplify genomic data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. Genome sequencing has increased in recent years following two decades of research demonstrating the promise of precision medicine. However, access to these advances has been limited by the significant time and expense required to interpret the genomic data.By integrating Watson for Genomics
Read More
